Projects per year
Personal profile
Education
- 2010-2015 Ph.D., Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University
- 1993-2000 M.D., School of Medicine, College of Medicine, Taipei Medical University
Experience
- 2025.08- Acting Director, Division of General Surgery, Department of Surgery, Taipei Medical University Shuang Ho Hospital
- 2024.08-2025.07 Vice Director, Department of Surgery, Taipei Medical University Shuang Ho Hospital
- Attending Physician, Taipei Medical University-Shuang Ho Hospital, Ministry of Health and Welfare
- 2023.02- Associate Professor, Department of Surgery, School of Medicine, Taipei Medical University
- 2016.03-2023.01 Assistant Professor, Department of Surgery, School of Medicine, Taipei Medical University
- 2007.08-2008.06 Attending Physician, Taipei Medical University Hospital
- 2002.07-2007.06 Resident Physician, Linkou Chang Gung Memorial Hospital
Fingerprint
Dive into the research topics where Chih-Ming Su is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 4 Finished
-
≫Combination of E1a Gene Therapy and Egfr Tyrosine Kinase Inhibitors in Tnbc: Preclinical Studies May Light up the New Therapeutic Strategy
Su, C.-M. (PI)
8/1/17 → 7/31/18
Project: A - Government Institution › b - National Science and Technology Council
-
Combination of E1A Gene Therapy and EGFR Tyrosine Kinase Inhibitors in TNBC---Preclinical Studies May Light up the New Therapeutic Strategy
Su, C.-M. (PI)
8/1/16 → 7/31/17
Project: A - Government Institution › b - National Science and Technology Council
-
開發及臨床前評估鈣黏蛋白11單株抗體作為抗藥性及轉移性乳癌的治療策略
Su, C.-M. (PI)
6/1/16 → 5/31/17
Project: C - Project of Alliance › u - Taipei Medical University Shuang Ho Hospital
-
研究合併E1A基因和表皮生長因子受體酪氨酸激?抑制劑在三重陰性乳癌臨床前治療的嶄新策略(1/3)
Su, C.-M. (PI)
8/1/15 → 7/31/16
Project: A - Government Institution › b - National Science and Technology Council
-
Disrupting CARMA3 Signaling with Triptolide Reverses Sorafenib Resistance in Hepatocellular Carcinoma
Wang, W. Y., Hsu, T. W., Su, Y. H., Su, C. M., Wang, T. H., Chiu, C. F., Tsai, K. Y., Huang, C. Y., Chen, H. A. & Liao, P. H., 2025, In: International Journal of Medical Sciences. 22, 16, p. 4353-4364 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Monitoring breast cancer progression through circulating methylated GCM2 and TMEM240 detection
Hung, C. S., Shen, H. T., Wang, P. Y., Su, C. M., Hsu, W. W., Chien, K. Y., Han, C. S., Liao, L. M. & Lin, R. K., Dec 2025, In: Clinical Epigenetics. 17, 1, 128.Research output: Contribution to journal › Article › peer-review
Open Access -
Standardized gynecologic consultation and bone surveillance in patients with breast cancer receiving hormone therapy
Chiu, C. W., Su, C. M., Liao, L. M., Su, Y. T., Wu, H. C. & Tam, K. W., Jun 2025, In: Supportive Care in Cancer. 33, 6, 479.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus) -
Upstaging Prediction Model to Guide the Application of Sentinel Lymph Node Biopsy in Patients With Ductal Carcinoma In Situ: A Retrospective Comparative Study
Chiu, C. W., Su, C. M., Liao, L. M., Su, C. S., Phan, T. P. & Tam, K. W., Mar 2025, In: Journal of Surgical Oncology. 131, 4, p. 571-579 9 p.Research output: Contribution to journal › Article › peer-review
-
Hypermethylation of the Gene Body in SRCIN1 Is Involved in Breast Cancer Cell Proliferation and Is a Potential Blood-Based Biomarker for Early Detection and a Poor Prognosis
Shen, H. T., Hung, C. S., Davis, C., Su, C. M., Liao, L. M., Shih, H. M., Lee, K. D., Ansar, M. & Lin, R. K., May 2024, In: Biomolecules. 14, 5, 571.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus)